Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Regulation of Viral Replication, Apoptosis and Pro-Inflammatory Responses by 17-AAG during Chikungunya Virus Infection in Macrophages.

Nayak TK, Mamidi P, Kumar A, Singh LP, Sahoo SS, Chattopadhyay S, Chattopadhyay S.

Viruses. 2017 Jan 6;9(1). pii: E3. doi: 10.3390/v9010003.

2.

Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.

Lundberg L, Pinkham C, de la Fuente C, Brahms A, Shafagati N, Wagstaff KM, Jans DA, Tamir S, Kehn-Hall K.

PLoS Negl Trop Dis. 2016 Nov 30;10(11):e0005122. doi: 10.1371/journal.pntd.0005122.

3.

Analysis of chikungunya virus proteins reveals that non-structural proteins nsP2 and nsP3 exhibit RNA interference (RNAi) suppressor activity.

Mathur K, Anand A, Dubey SK, Sanan-Mishra N, Bhatnagar RK, Sunil S.

Sci Rep. 2016 Nov 30;6:38065. doi: 10.1038/srep38065.

4.

In silico study on anti-Chikungunya virus activity of hesperetin.

Oo A, Hassandarvish P, Chin SP, Lee VS, Abu Bakar S, Zandi K.

PeerJ. 2016 Oct 26;4:e2602.

5.

Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells.

Ruiz Silva M, van der Ende-Metselaar H, Mulder HL, Smit JM, Rodenhuis-Zybert IA.

Sci Rep. 2016 Aug 25;6:32288. doi: 10.1038/srep32288.

6.
7.

Alphavirus Infection: Host Cell Shut-Off and Inhibition of Antiviral Responses.

Fros JJ, Pijlman GP.

Viruses. 2016 Jun 11;8(6). pii: E166. doi: 10.3390/v8060166. Review.

9.

Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.

Forsyth KS, Eisenlohr LC.

Curr Opin Immunol. 2016 Jun;40:123-9. doi: 10.1016/j.coi.2016.03.003. Review.

PMID:
27115617
10.

Versatile Trans-Replication Systems for Chikungunya Virus Allow Functional Analysis and Tagging of Every Replicase Protein.

Utt A, Quirin T, Saul S, Hellström K, Ahola T, Merits A.

PLoS One. 2016 Mar 10;11(3):e0151616. doi: 10.1371/journal.pone.0151616.

11.

Chikungunya nsP2 protease is not a papain-like cysteine protease and the catalytic dyad cysteine is interchangeable with a proximal serine.

Saisawang C, Saitornuang S, Sillapee P, Ubol S, Smith DR, Ketterman AJ.

Sci Rep. 2015 Nov 24;5:17125. doi: 10.1038/srep17125.

12.

Chikungunya vaccines in development.

Schwameis M, Buchtele N, Wadowski PP, Schoergenhofer C, Jilma B.

Hum Vaccin Immunother. 2016 Mar 3;12(3):716-31. doi: 10.1080/21645515.2015.1101197.

13.

Phosphorylation of Single Stranded RNA Virus Proteins and Potential for Novel Therapeutic Strategies.

Keck F, Ataey P, Amaya M, Bailey C, Narayanan A.

Viruses. 2015 Oct 12;7(10):5257-73. doi: 10.3390/v7102872. Review.

14.

Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus.

Fros JJ, Geertsema C, Zouache K, Baggen J, Domeradzka N, van Leeuwen DM, Flipse J, Vlak JM, Failloux AB, Pijlman GP.

Parasit Vectors. 2015 Sep 17;8:464. doi: 10.1186/s13071-015-1070-4.

15.

Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway.

Joubert PE, Stapleford K, Guivel-Benhassine F, Vignuzzi M, Schwartz O, Albert ML.

PLoS Pathog. 2015 Aug 28;11(8):e1005091. doi: 10.1371/journal.ppat.1005091.

16.

Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion.

Stapleford KA, Rozen-Gagnon K, Das PK, Saul S, Poirier EZ, Blanc H, Vidalain PO, Merits A, Vignuzzi M.

J Virol. 2015 Nov;89(22):11233-44. doi: 10.1128/JVI.01553-15.

17.

Mechanisms of innate immune evasion in re-emerging RNA viruses.

Ma DY, Suthar MS.

Curr Opin Virol. 2015 Jun;12:26-37. doi: 10.1016/j.coviro.2015.02.005. Review.

19.

Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2.

Utt A, Das PK, Varjak M, Lulla V, Lulla A, Merits A.

J Virol. 2015 Mar;89(6):3145-62. doi: 10.1128/JVI.03213-14. Erratum in: J Virol. 2016 Sep 1;90(17):8030.

20.

Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection.

Poo YS, Rudd PA, Gardner J, Wilson JA, Larcher T, Colle MA, Le TT, Nakaya HI, Warrilow D, Allcock R, Bielefeldt-Ohmann H, Schroder WA, Khromykh AA, Lopez JA, Suhrbier A.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3354. doi: 10.1371/journal.pntd.0003354.

Items per page

Supplemental Content

Support Center